Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Durez

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Rheumatology|October 7, 2020
Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseasesP Sidiras, D Spruyt, V Gangji, et al.
The Journal of Experimental Medicine|February 1, 1993
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin AP Durez, D Abramowicz, C Gérard, et al.
Diagnostic and Interventional Imaging|August 25, 2020
Diagnostic performance of sacroiliac joint MRI and added value of spine MRI to detect active spondyloarthritisM Plier, A Nzeusseu Toukap, N Michoux, et al.
Arthritis and Rheumatism|February 1, 1997
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destructionL A Joosten, E Lubberts, P Durez, et al.
Annals of the Rheumatic Diseases|February 16, 2008
Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritisP C P M Verschueren, R J U Lories, M Daans, et al.
Journal of Medical Virology|November 1, 1994
Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndromeM Willems, L Sheng, T Roskams, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trialJ Kekow, R J Moots, P Emery, et al.
Annals of the Rheumatic Diseases|August 17, 2004
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatmentP Durez, A Nzeusseu Toukap, B R Lauwerys, et al.
Arthritis and Rheumatism|February 22, 2011
Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synoviumI Gutierrez-Roelens, C Galant, I Theate, et al.
Rheumatology (Oxford, England)|February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective studyP Durez, F Van den Bosch, L Corluy, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Rheumatology|October 7, 2020
Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseasesP Sidiras, D Spruyt, V Gangji, et al.
The Journal of Experimental Medicine|February 1, 1993
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin AP Durez, D Abramowicz, C Gérard, et al.
Diagnostic and Interventional Imaging|August 25, 2020
Diagnostic performance of sacroiliac joint MRI and added value of spine MRI to detect active spondyloarthritisM Plier, A Nzeusseu Toukap, N Michoux, et al.
Arthritis and Rheumatism|February 1, 1997
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destructionL A Joosten, E Lubberts, P Durez, et al.
Annals of the Rheumatic Diseases|February 16, 2008
Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritisP C P M Verschueren, R J U Lories, M Daans, et al.
Journal of Medical Virology|November 1, 1994
Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndromeM Willems, L Sheng, T Roskams, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trialJ Kekow, R J Moots, P Emery, et al.
Annals of the Rheumatic Diseases|August 17, 2004
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatmentP Durez, A Nzeusseu Toukap, B R Lauwerys, et al.
Arthritis and Rheumatism|February 22, 2011
Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synoviumI Gutierrez-Roelens, C Galant, I Theate, et al.
Rheumatology (Oxford, England)|February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective studyP Durez, F Van den Bosch, L Corluy, et al.
Pageof 4